Bipolar I Disorder clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Open-Label, Flexible-dose Study to Evaluate the Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia or Bipolar I Disorder
Sorry, not currently recruiting here
The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizophrenia or bipolar I disorder, and to establish the benefit-risk profile of long-term treatment in this population
San Diego, California and other locations
Last updated: